Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical company with a broad portfolio of oncology products under development, announced today that it will release its second quarter 2006 financial results on Wednesday, August 9, 2006, followed by a conference call to discuss the results and provide a corporate update on Thursday, August 10, 2006 at 10 a.m. EST. Adherex’s Chairman and CEO Dr. William Peters and Chief Financial Officer Jim Klein will host the call.
